Catherine Angell Sohn's Insider Trades & SAST Disclosures
Catherine Angell Sohn's most recent trade in Altimmune Inc was a trade of 1,000 Common Stock, par value $0.0001 done at an average price of $5.8 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Catherine Angell Sohn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Altimmune Inc | Catherine Angell Sohn | Director | Purchase of securities on an exchange or from another person at price $ 5.78 per share. | 17 Mar 2025 | 1,000 | 1,000 (0%) | 0% | 5.8 | 5,785 | Common Stock, par value $0.0001 |
| Altimmune Inc | Catherine Angell Sohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 18,600 | 18,600 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Catherine Angell Sohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 34,900 | 34,900 | - | - | Stock Options (option to buy) | |
| Altimmune Inc | Angell Sohn Catherine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2023 | 26,100 | 26,100 | - | - | Stock Options (option to buy) | |
| Jazz Pharmaceuticals plc | Catherine Angell Sohn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 3,075 | 16,109 (0%) | 0% | 0 | Ordinary Shares | |
| Jazz Pharmaceuticals plc | Catherine Angell Sohn | Director | Sale of securities on an exchange or to another person at price $ 138.16 per share. | 11 Aug 2023 | 1,241 | 14,868 (0%) | 0% | 138.2 | 171,455 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges